Group One Trading
NVNO

Group One Trading’s enVVeno Medical NVNO Stock Holding History

Group One Trading’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6
Closed -$798 – 8909
2025
Q2 		$798 Sell
6
-371
-98% -$43.9K ﹤0.01% 7602
2025
Q1 		$34.7K Buy
+377
New +$42K ﹤0.01% 5447
2024
Q4 		– Sell
-120
Closed -$14.1K – 7746
2024
Q3 		$14.1K Buy
+120
New +$22K ﹤0.01% 5427
2024
Q2 		– Sell
-526
Closed -$100K – 7242
2024
Q1 		$100K Hold
526
– – ﹤0.01% 4154
2023
Q4 		$94.6K Buy
+526
New +$83.8K ﹤0.01% 4514

Other funds holding NVNO

KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Group One Trading's NVNO Position: Q2 2026 in Review

Group One Trading held its enVVeno Medical (NVNO) position steady in Q2 2026 at 2 shares worth $21. The position accounts for ﹤0.01% of the portfolio, ranked #7443.

Group One Trading first reported a position in NVNO in Q3 2023 and has held it in 7 quarters since. The position peaked at $34.3K in Q3 2023. 17 funds tracked by Wall St. Rank hold NVNO as of Q2 2026.

  • Group One Trading held 2 shares of enVVeno Medical worth $21 as of Q2 2026.
  • Group One Trading left its enVVeno Medical share count unchanged in Q2 2026.
  • enVVeno Medical made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7443 holding.
  • Group One Trading first reported a position in enVVeno Medical in Q3 2023 and has held it in 7 quarters since.
  • Group One Trading's enVVeno Medical position peaked at $34.3K in Q3 2023.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.